INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 28 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $584,566 | +2.9% | 590,000 | 0.0% | 0.16% | +26.6% |
Q2 2023 | $567,975 | +4.8% | 590,000 | 0.0% | 0.12% | -20.5% |
Q1 2023 | $541,880 | -1.7% | 590,000 | 0.0% | 0.16% | -20.4% |
Q4 2022 | $551,420 | -4.6% | 590,000 | 0.0% | 0.20% | -14.4% |
Q3 2022 | $578,000 | +3.8% | 590,000 | 0.0% | 0.23% | +15.1% |
Q2 2022 | $557,000 | -5.6% | 590,000 | 0.0% | 0.20% | -17.4% |
Q1 2022 | $590,000 | -2.8% | 590,000 | 0.0% | 0.24% | -14.8% |
Q4 2021 | $607,000 | -0.7% | 590,000 | 0.0% | 0.28% | +3.7% |
Q3 2021 | $611,000 | -1.5% | 590,000 | 0.0% | 0.27% | -12.8% |
Q2 2021 | $620,000 | -96.6% | 590,000 | -96.3% | 0.31% | -93.7% |
Q1 2021 | $18,014,000 | +96.4% | 16,130,000 | +100.0% | 4.98% | -23.8% |
Q4 2020 | $9,173,000 | -6.8% | 8,065,000 | -11.0% | 6.54% | -22.9% |
Q3 2020 | $9,846,000 | +11.4% | 9,065,000 | 0.0% | 8.48% | +25.4% |
Q2 2020 | $8,837,000 | +17.3% | 9,065,000 | +0.7% | 6.76% | +20.9% |
Q1 2020 | $7,536,000 | +678.5% | 9,000,000 | +800.0% | 5.59% | +624.6% |
Q4 2019 | $968,000 | – | 1,000,000 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |